Tag Archive: ZERO prostate cancer news

Between the Sheets | July 2022

QUESTION FROM PROSTATE CANCER SURVIVOR: I am a 52-year old gay man whose 10-year relationship just ended. That was a... Read More

Progress in Prostate Cancer Research | Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

By Zachary Klaassen, MD, MSc If you’ve been diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), you have many treatment options.... Read More

ZERO featured in “One Hour Cares” charity contest

HAMPTON ROADS, Va. – ZERO is the leading national nonprofit with the mission to end prostate cancer through advancing research,... Read More

Al Roker walks the runway to support ZERO’s Blue Jacket Fashion Show

toTODAY’s Al Roker walked the runway at the Blue Jacket Fashion Show on Thursday. Roker strutted the catwalk for a... Read More

Andre Leon Talley honored at ZERO’s Blue Jacket Show

Vogue’s first and only black creative director, André Leon Talley, will be honored at New York Fashion Week on Thursday,... Read More

Treatment with abiraterone significantly improves survival in advanced prostate cancer

In December, researchers reported findings from a study showing that the drug abiraterone halves the risk of prostate cancer death among... Read More

New Partnership Formed to Promote Early Cancer Detection

Washington, D.C. (December 20, 2021) – Today marks the formation of The Cancer Early Detection Alliance (CEDA), a unique collaboration... Read More

3D imaging method may help doctors better determine prostate cancer aggressiveness

Prostate cancer is the most common cancer for men and, for men in the United States, it’s the second leading... Read More

Inherited mutation linked to aggressive prostate cancer

Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter... Read More

Clinical Pathways and Veterans

My name is Sherry Denton, and I am a nurse practitioner, the director of a prostate cancer clinic in Little... Read More

1 2 3 4